Ignite Creation Date:
2024-05-06 @ 2:22 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04292119
Status:
UNKNOWN
Last Update Posted:
2021-03-10
First Post:
2020-02-26
Brief Title:
Lorlatinib Combinations in Lung Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
| Anaplastic Lymphoma Kinase Gene Translocation |
| ROS1 Rearrangement |
| Relapsed Cancer |
| MET Amplification |
| Resistant Cancer |
| NSCLC |